Conbercept for patients with age-related macular degeneration: a systematic review [PDF]
BMC Ophthalmology, 2018 Background Conbercept is a novel vascular endothelial growth factor (VEGF) inhibitor for the treatment of wet age-related macular degeneration (AMD). This systematic review aims to assess the efficacy and safety of conbercept in the treatment of wet AMD.
Jiaxing Zhang +7 more
doaj +4 more sources
A Study on the Drug Concentration in Fellow Eyes After Unilateral Intravitreal Injection of Conbercept Into New Zealand Rabbit Eyes [PDF]
Frontiers in Pharmacology, 2021 Intravitreal injections of anti-vascular endothelial growth factor (VEGF) have become increasingly popular in the treatment of ocular diseases. However, few studies have determined the efficiency of unilateral intravitreal anti-VEGF injection in the ...
Yu Di, Haiyan Xu, Junjie Ye, Zijian Guo
doaj +2 more sources
Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2022 AIM: To explore the efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of central retinal vein occlusion (CRVO) through optical coherence tomography angiography (OCTA). METHODS: Patients with prior treatment of a minimum of three
Tong Zhao +4 more
doaj +2 more sources
Conbercept Treatment for Heart-Shaped Vascular Intertwined Nets in Macular Neovascularization: Anti-VEGF Drug Therapy Strategy Based on Vascular Geometry Diagnosed by OCTA. [PDF]
Clin Case RepA 63‐year‐old male with a history of hypertension and diabetes developed acute vision loss, which was attributed to macular neovascularization secondary to hypertensive retinopathy. Optical coherence tomography angiography revealed unusual heart‐shaped, intertwined vascular nets, informing the choice of Conbercept for intravitreal injection.
Ou S, Shi F, Cai M, Wu Y.
europepmc +2 more sources
Enhancement of retinal Müller glia’s phagocytic activity against hard exudates by conbercept via activation of PPARγ-CD36 axis in diabetic retinopathy [PDF]
International Journal of OphthalmologyAIM: To investigate the effects and the underlying mechanism(s) of conbercept on the phagocytosis of hard exudates (HEs) by Müller glia in diabetic retinopathy (DR).
Ying-Ying Zhu +7 more
doaj +2 more sources
Efficacy of Intravitreal Conbercept in Vitrectomy for Proliferative Diabetic Retinopathy: An Integrated Meta-Analysis and Bibliometric Study [PDF]
Clinical OphthalmologyGuangda Li,1,* Mingxuan Zhang,2,* Yifeng Ke,2 Chuanzhen Zheng,3 Liangzhang Tan,2 Yongtao Li,2 Emmanuel Eric Pazo,2 Chunli Chen,4 Xinjun Ren2 1Department of Ophthalmology, Linyi People’ s Hospital, Linyi, Shandong, People’s Republic of ...
Li G +8 more
doaj +2 more sources
Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy [PDF]
Journal of Ophthalmology, 2018 Introduction. To compare the effect and safety of intravitreal conbercept (IVC), intravitreal ranibizumab (IVR), or intravitreal triamcinolone acetonide (IVTA) injection on 23-gauge (23-G) pars plana vitrectomy (PPV) for proliferative diabetic ...
Jinglin Cui +8 more
doaj +2 more sources
Review of Retinopathy of Prematurity Management in the Anti-VEGF Era: Evolving Global Paradigms, Persistent Challenges and Our AI-Assisted Future. [PDF]
Clin Exp OphthalmolABSTRACT Retinopathy of prematurity (ROP) remains a major cause of preventable blindness in premature infants worldwide, with increasing incidence due to advancements in neonatal care. Management of ROP has been revolutionised by anti‐vascular endothelial growth factor (anti‐VEGF) treatments.
Marra KV +3 more
europepmc +2 more sources
Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation [PDF]
Frontiers in PharmacologyObjectiveThe present study aims to evaluate the ocular pharmacokinetics of intravitreal conbercept after retinal scatter laser photocoagulation.MethodsThirty male Chinchilla rabbits (60 eyes) were used in this study.
Lanlan Chen +6 more
doaj +2 more sources
Conbercept combined with 577 nm subthreshold micropulse laser for diabetic macular edema [PDF]
International Journal of OphthalmologyAIM: To evaluate the efficacy and safety of conbercept combined with 577 nm subthreshold micropulse laser (STML) for treatment of diabetic macular edema (DME). METHODS: A retrospective study was conducted.
Ying Han +7 more
doaj +2 more sources